FXR2
Basic information
Region (hg38): 17:7591230-7614897
Previous symbols: [ "FMR1L2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FXR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 37 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 4 | 1 |
Variants in FXR2
This is a list of pathogenic ClinVar variants found in the FXR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-7591891-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
17-7591901-T-C | Likely benign (Jul 31, 2018) | |||
17-7592268-G-C | not specified | Uncertain significance (Sep 01, 2021) | ||
17-7592282-G-A | not specified | Uncertain significance (Jan 24, 2023) | ||
17-7592342-T-C | not specified | Uncertain significance (Mar 23, 2022) | ||
17-7592349-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
17-7592525-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
17-7592533-T-A | not specified | Uncertain significance (Oct 25, 2023) | ||
17-7592542-T-C | not specified | Uncertain significance (Oct 22, 2021) | ||
17-7592548-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
17-7592580-T-A | not specified | Uncertain significance (Dec 28, 2022) | ||
17-7592696-A-G | not specified | Uncertain significance (Jan 31, 2024) | ||
17-7592738-C-G | not specified | Uncertain significance (Feb 07, 2023) | ||
17-7592741-T-C | not specified | Uncertain significance (Dec 15, 2023) | ||
17-7592744-A-T | not specified | Uncertain significance (Apr 05, 2024) | ||
17-7592748-C-G | not specified | Uncertain significance (May 24, 2024) | ||
17-7592774-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
17-7592777-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
17-7592778-G-A | not specified | Uncertain significance (May 23, 2023) | ||
17-7592778-G-C | not specified | Uncertain significance (Apr 19, 2024) | ||
17-7592786-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
17-7592805-G-T | not specified | Uncertain significance (Feb 16, 2023) | ||
17-7592810-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
17-7592810-G-C | not specified | Uncertain significance (Jun 21, 2023) | ||
17-7592834-G-A | not specified | Uncertain significance (Feb 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FXR2 | protein_coding | protein_coding | ENST00000250113 | 17 | 23642 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000381 | 124637 | 0 | 2 | 124639 | 0.00000802 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.62 | 258 | 407 | 0.634 | 0.0000257 | 4281 |
Missense in Polyphen | 85 | 182.33 | 0.46619 | 1727 | ||
Synonymous | 0.416 | 140 | 146 | 0.956 | 0.00000778 | 1382 |
Loss of Function | 5.58 | 3 | 42.0 | 0.0715 | 0.00000287 | 412 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000887 | 0.00000885 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein.;
- Pathway
- RNA transport - Homo sapiens (human);miR-targeted genes in lymphocytes - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- rvis_EVS
- -0.53
- rvis_percentile_EVS
- 20.7
Haploinsufficiency Scores
- pHI
- 0.411
- hipred
- Y
- hipred_score
- 0.576
- ghis
- 0.588
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.591
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fxr2
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of translation;regulation of mRNA stability;positive regulation of translation
- Cellular component
- nucleus;cytoplasm;cytosol;polysome;postsynaptic density;membrane;cytosolic large ribosomal subunit;axon;ribonucleoprotein granule;cytoplasmic ribonucleoprotein granule;neuronal cell body;dendritic spine
- Molecular function
- RNA binding;mRNA binding;mRNA 3'-UTR binding;protein binding;identical protein binding;protein homodimerization activity;translation regulator activity;protein heterodimerization activity